Which Hepatitis types are most commonly seen in intravenous drug users, and what is the vaccine status for these types?

Which Hepatitis types are most commonly seen in intravenous drug users, and what is the vaccine status for these types?

• A. Hepatitis A and E with vaccines available for A
• B. Hepatitis B and C with vaccines available for B (and A)
• C. Hepatitis C and D with vaccines available for D
• D. Hepatitis A and B with vaccines available for A and B

Answer: (B)

The main idea tested is which hepatitis types are most linked to intravenous drug use and what their vaccination options look like. Intravenous drug use creates a high risk of bloodborne transmission, so hepatitis B and hepatitis C are the types most commonly seen in this group. Hepatitis B has an effective vaccine that can prevent infection, which is why vaccination is strongly recommended for those at risk. Hepatitis C, on the other hand, has no vaccine available (although antiviral treatments exist), so vaccination cannot prevent C. Among the options, the best match names the two types most associated with IDU and notes that a vaccine is available for the one that can be prevented, while the other has no vaccine. There is also a vaccine for hepatitis A, but it does not change the fact that B and C are the primary pair of concern for IDUs, with the vaccine status aligning with B having a vaccine and C not.

The main idea tested is which hepatitis types are most linked to intravenous drug use and what their vaccination options look like. Intravenous drug use creates a high risk of bloodborne transmission, so hepatitis B and hepatitis C are the types most commonly seen in this group. Hepatitis B has an effective vaccine that can prevent infection, which is why vaccination is strongly recommended for those at risk. Hepatitis C, on the other hand, has no vaccine available (although antiviral treatments exist), so vaccination cannot prevent C.

Among the options, the best match names the two types most associated with IDU and notes that a vaccine is available for the one that can be prevented, while the other has no vaccine. There is also a vaccine for hepatitis A, but it does not change the fact that B and C are the primary pair of concern for IDUs, with the vaccine status aligning with B having a vaccine and C not.